Mary G Johnson

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Bone Regeneration

Top Venues

Patient preference and adherence

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)
Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)